From hype to evidence: What real-world GLP-1 data means for insurers Published date: 16 Apr 2026 Published by: Reinsurance Content Type: Publication Swiss Re analyzes real‑world GLP‑1 usage (2020–2025), showing accelerating uptake, rising non‑diabetic use, and links between ... By Multiple Authors Go to From hype to evidence: What real-world GLP-1 data means for insurers
sigma insights 05/2026: Ultra-processed foods: evolving liability landscape Published date: 11 Mar 2026 Published by: Swiss Re Institute Content Type: Publication Ultra-processed foods (UPFs) are a long-tail risk with liability excess inflation dynamics By Multiple Authors Go to sigma insights 05/2026: Ultra-processed foods: evolving liability landscape
Disclosure by design: How insurers can close the GLP-1 disclosure gap with behavioural science Published date: 25 Nov 2025 Published by: Reinsurance Content Type: Publication Discover how Swiss Re’s research reveals why GLP-1 medication use is often under-disclosed and how behaviourally informed ... By Multiple Authors Go to Disclosure by design: How insurers can close the GLP-1 disclosure gap with behavioural science
Changing mental health trends in Netherlands Published date: 06 Aug 2025 Published by: Swiss Re Group Content Type: Publication Explore the evolving mental health trends in Netherlands impacting disability insurance, young adults, and systemic risk challenges. By Multiple Authors Go to Changing mental health trends in Netherlands
Cancer survivors’ Right to be Forgotten (RTBF) Implications for Life & Health insurers Published date: 06 Jun 2025 Published by: Reinsurance Content Type: Publication The Right to be Forgotten allows cancer survivors to withhold past diagnoses, reshaping insurance norms and requiring localised ... By Multiple Authors Go to Cancer survivors’ Right to be Forgotten (RTBF) Implications for Life & Health insurers
New hope for curing (and insuring) more individuals with HIV Published date: 09 Mar 2022 Published by: Reinsurance Content Type: Blog First case of a woman who appears to be cured of HIV. She also is the first racially diverse individual to be cured of HIV ... By Multiple Authors Go to New hope for curing (and insuring) more individuals with HIV
Unlocking the Capabilities of your Swiss Re L&H Underwriting Team Published date: 26 Oct 2022 Published by: Reinsurance Content Type: Blog Underwriting is changing by the day, clients need to be able to rely on the expertise and insight of their reinsurance ... By Bess Ganeff, Head L&H Underwriting & Claims US Go to Unlocking the Capabilities of your Swiss Re L&H Underwriting Team
Sustainably Protecting Our Mental Health Published date: 11 Oct 2022 Published by: Reinsurance Content Type: Blog According to Swiss Re's Global COVID-19 Consumer Survey, a third of people in the US reported a deterioration of their mental ... By Shelly Habecker, L&H Sustainability Lead, CUO L&H Reinsurance Go to Sustainably Protecting Our Mental Health
Thematic Investing: fostering a healthier, resilient society and a greener, more digitized economy Published date: 03 May 2022 Published by: Swiss Re Group Content Type: Blog We've identified three key themes underpinned by strong secular tailwinds: healthcare, digital infrastructure and energy ... By Guido Fürer, Former Group Chief Investment Officer Go to Thematic Investing: fostering a healthier, resilient society and a greener, more digitized economy
Gene & Cell Therapies (GCT) –The Future of Cost Containment and Risk Forecasting Published date: 01 Apr 2022 Published by: Reinsurance Content Type: Blog We're living in a time when previously incurable diseases and illnesses will be curable with novel treatments like gene and cell ... By Agostino Marotta, Former US Medical Underwriting Manager Go to Gene & Cell Therapies (GCT) –The Future of Cost Containment and Risk Forecasting
